A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
Status:
Withdrawn
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The primary research question of this study is: Does the pharmacokinetics of oseltamivir
after a single oral dose differ between the pregnant and non-pregnant women?
Phase:
Phase 1
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH)